Terms: = Pancreatic cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
327 results:
1. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated emt via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
2. Investigation of ENO2 as a promising novel marker for the progression of colorectal cancer with microsatellite instability-high.
Cai J; Yang Y; Zhang L; Fang Y; Zhang Y; Tan M; Zhang J; Tang C; Ren H; Wang L; Xiang G; Xu F; Lan L; Li L; Zheng X
BMC Cancer; 2024 May; 24(1):573. PubMed ID: 38724951
[TBL] [Abstract] [Full Text] [Related]
3. Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/emt Subtype and MMP12 Linked to the Progression and prognosis in Hepatocellular Carcinoma.
Zuo A; Li J; Weng S; Xu H; Zhang Y; Wang L; Xing Z; Luo P; Cheng Q; Li J; Han X; Liu Z
J Proteome Res; 2024 May; 23(5):1821-1833. PubMed ID: 38652053
[TBL] [Abstract] [Full Text] [Related]
4. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract] [Full Text] [Related]
5. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA
Wei Y; Zhu P
Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
[TBL] [Abstract] [Full Text] [Related]
7. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
8. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract] [Full Text] [Related]
9. The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes.
Ye Z; Li Q; Hu Y; Hu H; Xu J; Guo M; Zhang W; Lou X; Wang Y; Gao H; Jing D; Fan G; Qin Y; Zhang Y; Chen X; Chen J; Xu X; Yu X; Liu M; Ji S
Cancer Lett; 2024 Apr; 588():216769. PubMed ID: 38438098
[TBL] [Abstract] [Full Text] [Related]
10. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
11. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.
Joseph AM; Al Aiyan A; Al-Ramadi B; Singh SK; Kishore U
Front Immunol; 2024; 15():1323198. PubMed ID: 38384463
[TBL] [Abstract] [Full Text] [Related]
12. Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2.
Yang H; Li Z; Zhu S; Wang W; Zhang J; Zhao D; Zhang M; Zhu W; Xu W; Xu C
Front Immunol; 2024; 15():1347683. PubMed ID: 38343537
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
Dang C; Bian Q; Wang F; Wang H; Liang Z
Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
[TBL] [Abstract] [Full Text] [Related]
14. KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract] [Full Text] [Related]
15. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive analyses and experimental verification of NETs and an emt gene signature for prognostic prediction, immunotherapy, and chemotherapy in pancreatic adenocarcinoma.
Zhang J; Wang C; Yu Y
Environ Toxicol; 2024 Apr; 39(4):2006-2023. PubMed ID: 38088494
[TBL] [Abstract] [Full Text] [Related]
17. GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition.
Li M; Wang X; Chen X; Hong J; Du Y; Song D
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166925. PubMed ID: 38084873
[TBL] [Abstract] [Full Text] [Related]
18. GATA6-AS1 suppresses epithelial-mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability.
Zhou Y; Zhou X; Ben Q; Liu N; Wang J; Zhai Y; Bao Y; Zhou L
J Transl Med; 2023 Dec; 21(1):882. PubMed ID: 38057853
[TBL] [Abstract] [Full Text] [Related]
19. Kinase D-interacting Substrate of 220 kDa Is Overexpressed in Gastric cancer and Associated With Local Invasion.
Cai S; Sun Z; Gao X; Ji KE; Ruge F; Shankla D; Liu X; Jiang WG; Ye L
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):735-743. PubMed ID: 38035704
[TBL] [Abstract] [Full Text] [Related]
20. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
[TBL] [Abstract] [Full Text] [Related]
[Next]
